表紙
市場調査レポート

世界におけるコンパニオン診断市場の予測

Global Companion Diagnostics Market 2014-2018

発行 TechNavio (Infiniti Research Ltd.) 商品コード 298805
出版日 ページ情報 英文 62 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.85円で換算しております。
Back to Top
世界におけるコンパニオン診断市場の予測 Global Companion Diagnostics Market 2014-2018
出版日: 2014年03月28日 ページ情報: 英文 62 Pages
概要

コンパニオン診断は、患者への投与に適した医薬品の特定や、医薬品投与後の経過観察を行うために使用されます。この医薬品と診断検査の組合せの概念は、予測医療や個別化医療と呼ばれています。コンパニオン診断検査は、罹患リスクの予測、疾患の診断、治療反応の観察を可能にします。世界のコンパニオン診断市場は、2013年から2018年にかけて、18.59%の複合年間成長率(CAGR)で拡大する見込みです。

当レポートでは、世界におけるコンパニオン診断市場の現況と成長の見通し、成長因子と課題、主要ベンダーの情報などを提供しており、概略以下の構成でお届けします。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 地理区分

第8章 購入基準

第9章 市場成長因子

第10章 成長因子とその影響

第11章 市場の課題

第12章 成長因子と課題の影響

第13章 市場動向

第14章 動向とその影響

第15章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • その他の有力ベンダー

第16章 主要ベンダーの分析

  • Agilent Technologies Inc.
  • Abbott Laboratories
  • bioMerieux SA.
  • Genomic Health Inc.
  • Roche Holding AG
  • Qiagen N.V.

第17章 関連レポート

目次
Product Code: IRTNTR3416

About Companion Diagnostics

Companion diagnostics is used to identify suitable patients to whom specific drugs can be administered and it monitors the prognosis of the effects of the drug(s) on the disease. This concept of combining a drug with a diagnostic test is termed predictive medicine or personalized medicine. The companion diagnostic test has the ability to predict disease risk, diagnose disease, and monitor the therapeutic response. The tests enable physicians to make informed decisions on the type of drugs to use and the dosage in order to attempt to reduce the mortality rate of diseases such as cancer and neurodegenerative disorders.

TechNavio's analysts forecast the Global Companion Diagnostics market will grow at a CAGR of 18.59 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Companion Diagnostics market for the period 2013-2018. To calculate the market size, the report considers revenue generated from the sales of companion diagnostic tests and associated kits provided by the vendors. It also presents the vendor landscape and a corresponding detailed analysis of key five vendors in the Global Companion Diagnostics market. The market is highly fragmented, with the presence of many small and large vendors. It includes vendors that operate across the globe and have a substantial presence in North America and the European Union. In addition, the report discusses the major drivers that influence the growth of the Global Companion Diagnostics market. It also outlines the challenges faced by vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio's report, the Global Companion Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Companion Diagnostics market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • Agilent Technologies Inc.
  • bioMerieux SA
  • Qiagen N.V.
  • Roche Holding AG

Other Prominent Vendors

  • 20/20 Genesystems Inc.
  • A & G Pharmaceutical Inc.
  • AccuTheranostics Inc.
  • Alacris Theranostics GmbH
  • AutoGenomics Inc.
  • Biogenex Laboratories Inc.
  • Leica Biosystems GmbH
  • Life Technologies Inc.
  • Luminex Corp.
  • pHLOGISTIX LLC
  • Spartan Bioscience Inc.
  • TheraDiag S.A.
  • Theranostics Health Inc.
  • Ventana Medical Systems Inc.

Key Market Driver

  • Increasing Focus on Reducing the Cost of Drug Discovery and Development.

For a full, detailed list, view our report.

Key Market Challenge

  • High Cost Associated with the Development of Companion Diagnostics.

For a full, detailed list, view our report.

Key Market Trend

  • Increase in Growth Strategies among Vendors

For a full, detailed list, view our report.

Key questions answered in this report:

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

1. Executive Summary

2. List of Abbreviations

3. Scope of the Report

  • 3.1. Market Overview
  • 3.2. Product Offerings

4. Market Research Methodology

  • 4.1. Market Research Process
  • 4.2. Research Methodology

5. Introduction

6. Market Landscape

  • 6.1. Market Overview
  • 6.2. Market Size and Forecast
  • 6.3. Five Forces Analysis

7. Geographical Segmentation

8. Buying Criteria

9. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape

  • 15.1. Competitive Scenario
    • 15.1.1. Key News
    • 15.1.2. Mergers and Acquisitions
  • 15.2. Other Prominent Vendors

16. Key Vendor Analysis

  • 16.1. Agilent Technologies Inc.
    • 16.1.1. Business Overview
    • 16.1.2. Business Segmentation
    • 16.1.3. Key Information
    • 16.1.4. SWOT Analysis
  • 16.2. Abbott Laboratories
    • 16.2.1. Business Overview
    • 16.2.2. Business Segmentation
    • 16.2.3. Key Information
    • 16.2.4. SWOT Analysis
  • 16.3. bioMerieux SA.
    • 16.3.1. Business Overview
    • 16.3.2. Business Segmentation
    • 16.3.3. Key Information
    • 16.3.4. SWOT Analysis
  • 16.4. Genomic Health Inc.
    • 16.4.1. Business Overview
    • 16.4.2. Business Segmentation
    • 16.4.3. Key Information
    • 16.4.4. SWOT Analysis
  • 16.5. Roche Holding AG
    • 16.5.1. Business Overview
    • 16.5.2. Business Segmentation
    • 16.5.3. Key Information
    • 16.5.4. SWOT Analysis
  • 16.6. Qiagen N.V.
    • 16.6.1. Business Overview
    • 16.6.2. Business Segmentation
    • 16.6.3. Key Information
    • 16.6.4. SWOT Analysis

17. Other Reports in this Series

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global in vitro Diagnostic Market 2013-2018 (US$ billion)
  • Exhibit 3: Global In vitro Diagnostic Market 2013
  • Exhibit 4: Global Companion Diagnostics Market 2013-2018 (US$ billion)
  • Exhibit 5: Comparative Analysis of Y-o-Y Growth Rates of Companion Diagnostic and IVD, Global Markets (2013-2018)
  • Exhibit 6: Global Companion Diagnostics Market Segmentation by Indication, 2013
  • Exhibit 7: Global Companion Diagnostics Market Segmentation by Indication, 2013
  • Exhibit 8: Global Companion Diagnostics Market, By Geography 2013
  • Exhibit 9: Business Segmentation of Agilent Technologies Inc.
  • Exhibit 10: Business Segmentation of Abbott Laboratories
  • Exhibit 11: Business Segmentation of bioMerieux SA.
  • Exhibit 12: Business Segmentation of Roche Holding AG.
  • Exhibit 13: Business Segmentation of Qiagen N.V.
Back to Top